Innovative Biotech Expansion Libbs is investing in the construction of a new biopharmaceutical manufacturing facility, Libbs Biotech, presenting a significant opportunity to offer advanced biotech solutions, raw materials, and specialized equipment to support their growing biologics production capacity.

Strong Research Focus With a dedicated Center of Development and substantial investment in research and development, there is potential to collaborate on innovative drug development projects, provide research reagents, or supply cutting-edge laboratory equipment and technology.

Strategic Industry Partnerships The recent licensing agreement with Polpharma Biologics highlights Libbs’ interest in biosimilars and biologics, opening avenues for partnership, technology transfer, or co-development opportunities in biosimilar manufacturing and related services.

National Market Presence Operating extensively across Brazil with manufacturing facilities and distribution in over 1,100 municipalities, Libbs offers a strong platform for distribution partnerships, supply chain solutions, and localized healthcare initiatives targeting the Latin American market.

Financial Capacity & Growth Generating revenue between 250 and 500 million dollars with a large workforce, Libbs has significant financial capacity to invest in new projects, making it a viable partner for long-term collaborations in pharmaceutical development, manufacturing, and supply chain innovation.